Covered recipient · General Payments record
KAREN RODMAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$786.65
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $522.96 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $272.55 | 18 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $68.19 | 4 |
| PFIZER INC. | $67.24 | 4 |
| UCB, Inc. | $36.99 | 1 |
| Lilly USA, LLC | $33.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.29 | 1 |
| Merz Pharmaceuticals, LLC | $16.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192022
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.72 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963184 | CMS |
| ABBVIE INC. | $6.05 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963186 | CMS |
| ABBVIE INC. | $6.50 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963188 | CMS |
| ABBVIE INC. | $7.45 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963190 | CMS |
| ABBVIE INC. | $8.26 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963192 | CMS |
| ABBVIE INC. | $123.70 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963194 | CMS |
| ABBVIE INC. | $9.81 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963196 | CMS |
| ABBVIE INC. | $5.76 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963198 | CMS |
| ABBVIE INC. | $9.07 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963200 | CMS |
| ABBVIE INC. | $7.29 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963202 | CMS |
| ABBVIE INC. | $11.43 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963204 | CMS |
| ABBVIE INC. | $7.07 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963206 | CMS |
| ABBVIE INC. | $9.25 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963208 | CMS |
| ABBVIE INC. | $18.72 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963210 | CMS |
| ABBVIE INC. | $10.93 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963212 | CMS |
| ABBVIE INC. | $8.87 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963214 | CMS |
| ABBVIE INC. | $7.40 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963216 | CMS |
| ABBVIE INC. | $7.27 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105963218 | CMS |
| Lilly USA, LLC | $33.75 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135116473 | CMS |
| Merz Pharmaceuticals, LLC | $16.95 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137951042 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $19.17 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144506826 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $13.99 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144508496 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $16.40 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144512291 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $18.63 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144512327 | CMS |
| Novartis Pharmaceuticals Corporation | $27.29 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087339549 | CMS |
| PFIZER INC. | $17.55 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131545095 | CMS |
| PFIZER INC. | $17.64 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131666300 | CMS |
| PFIZER INC. | $14.96 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131643218 | CMS |
| PFIZER INC. | $17.09 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131786250 | CMS |
| UCB, Inc. | $36.99 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143398203 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.